The Efficacy and safety of rosuvastatin in patients with coronary heart disease

Kobalava Zh.D. ¹ , Stavtseva Yu.V. ¹

КАРДИОЛОГИЯ

KlinMed Consulting

11

Русский

80-87

Опубликовано

Внешняя ссылка

55

2015

• ¹ Peoples Friendship University of Russia, Moscow, Russian Federation

fluorobenzene; hydroxymethylglutaryl coenzyme A reductase inhibitor; pyrimidine derivative; rosuvastatin; sulfonamide; coronary artery disease; human; treatment outcome; Coronary Disease; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome